Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 722 participants.

Also called NCT06044597

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 722 participants (planned count) (from the registry)
Sponsor
Antonio Rapacciuolo (from the registry)
Registry
  • NCT NCT06044597
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06044597. Randomized; no masking; primary purpose treatment. Start 2023-10-01 (anticipated); primary completion 2026-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).
Acronym
CRUSTY +
Condition
Heart Failure
Intervention (Device)
SyncAV function on
Lead sponsor
Antonio Rapacciuolo (class: other)

Record details

Record id
cardio:ct-nct06044597
Content hash
9df6e19b107a6c02ce1555db0d329e153666233f63bcef207aff310f6a4eb5f7